A new regulation aims to ensure that the European Union offers an “attractive and favorable environment” for high-quality clinical research.
The pandemic may have spurred big changes in clinical trial design and conduct, but an FDA official says the key to prepping for an agency inspection remains the same.
The invasion of Ukraine by Russia has devastating consequences – for Ukraine, Russia, neighboring countries and the world at large. Thousands have been killed. Mass displacement and economic ruin is affecting millions. And no one knows how long the war will last or how bad the situation will get.
Finding the right balance of information to send to IRBs during remote trials is a delicate, but crucial, challenge, experts say.
A new white paper from ACRP assesses the significant implications of how decentralized clinical trials (DCTs) leverage digital technologies to interact remotely with trial participants.